CompletedPhase 2NCT05557110

Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chen Suning
Principal Investigator
Suning Chen, PHD
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Intervention
Blinatumomab(drug)
Enrollment
35 enrolled
Eligibility
15-65 years · All sexes
Timeline
20222024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05557110 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials